ArticleFrontiers in oncology2024

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.

Akihiro Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.